Cape Fear BioCapital Fund I, LP
Open, writing first checksEmerging manager
Open: first sale May 2024, per Form D (fund age approximates vintage)
- Vintage
- 2024
- Fund size
- $8.99M to $9.5M (Form D)
- Stages
- Pre-seed, Seed
- Sectors
- Biotech
- Regions
- NC
01 · Thesis
Cape Fear BioCapital is an early-stage venture firm backing therapeutics companies emerging from North Carolina's research ecosystem. It writes first checks at pre-seed to seed, targeting companies within three years of an IND filing with differentiated biology.Inferred from the firm's website
02 · Initial check
$60K to $119K (estimated from fund size)
Estimated from Form D: $8.99M sold of a $9.5M target
03 · Who to approach
No partners identified yet.
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideCape Fear BioCapital is an early-stage VC backing therapeutics companies emerging from North Carolina's research ecosystem.
Cape Fear BioCapital is an early-stage VC backing the next generation of therapeutics companies emerging from North Carolina's world-class research ecosystem.
https://www.capefearbiocap.com/
06 · Sources
Last verified: Oct 28, 2026